Phenotypic study of common TCM syndromes of colorectal cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ITMCTR

Registry ID

ITMCTR2100004653

Enrollment

Unknown

Registered

2021-03-27

Start date

2021-03-21

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Healthy control group:no

shireyunjie:no

pixushire:no

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) colorectal cancer diagnosed by pathology or cytology;2) Meet the diagnostic criteria of the syndrome phenotype group;3) No enteric infection within one month;4) Not using antibiotics and probiotics, and not drinking yogurt within one month;5) Do not use any antibiotic drugs during the voluntary study;6) Age =18, gender unlimited;7) The expected survival time of > was 3 months;8) Voluntary enrollment, patients or their family members signed the informed consent.

Exclusion criteria

Exclusion criteria: 1) Unable to cooperate, such as combined with neurological or mental disorders, or unwilling to cooperate;2) Pregnant and lactating women;3) Patients with severe respiratory, circulatory, urinary, neurological, digestive, hematopoietic and metabolic diseases.

Design outcomes

Primary

Measure	Time frame
Analysis of human serum metabolites;Analysis of composition of intestinal flora;	—

Countries

china

Contacts

Public ContactDayue Darrel DUAN

dduan@swmu.edu.cn18181893148

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026